Home/Filings/4/0001819790-23-000085
4//SEC Filing

YARNO WENDY L 4

Accession 0001819790-23-000085

CIK 0001819790other

Filed

Dec 4, 7:00 PM ET

Accepted

Dec 5, 6:27 PM ET

Size

6.9 KB

Accession

0001819790-23-000085

Insider Transaction Report

Form 4
Period: 2023-12-02
Transactions
  • Exercise/Conversion

    Common Stock

    2023-12-02+5,0007,000 total
  • Exercise/Conversion

    Restricted Stock Units

    2023-12-025,0000 total
    Common Stock (5,000 underlying)
Footnotes (3)
  • [F1]The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.
  • [F2]Each RSU represents a contingent right to receive one share of the Company's common stock.
  • [F3]RSUs granted in connection with the Reporting Person's service as the Lead Independent Director. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Issuer

Tarsus Pharmaceuticals, Inc.

CIK 0001819790

Entity typeother

Related Parties

1
  • filerCIK 0001181186

Filing Metadata

Form type
4
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 6:27 PM ET
Size
6.9 KB